{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T08:01:11Z","timestamp":1648972871660},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.transproceed.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T10:26:30Z","timestamp":1445941590000},"page":"2446-2449","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tacrolimus, Mycophenolate Mofetil, and Low-Dose Steroids With or\u00a0Without Interleukin-2 Receptor Antibody Induction Therapy: A\u00a0Retrospective Cohort Analysis"],"prefix":"10.1016","volume":"47","author":[{"given":"C.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"B\u00f6hmig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Steininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kristo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kozakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Berlakovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"M\u00fchlbacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2015.08.003_bib1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"CHIB 201 International Study Group. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2015.08.003_bib2","first-page":"CD003897","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2015.08.003_bib3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10157-008-0044-7","article-title":"Basiliximab induction therapy for live donor kidney transplantation: a long-term follow-up of prospective randomized controlled study","volume":"12","author":"Sheashaa","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2015.08.003_bib4","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00007890-199901270-00016","article-title":"United States Simulect Renal Study Group. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric antiinterleukin-2-receptor monoclonal antibody","volume":"67","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.08.003_bib5","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 14","key":"10.1016\/j.transproceed.2015.08.003_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-0012.2005.00393.x","article-title":"Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation","volume":"19","author":"Miura","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2015.08.003_bib7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.transproceed.2005.02.066","article-title":"Regimen of tacrolimus-based immunosuppression with basiliximab, mycophenolate mofetil, and low-dose steroid reduces acute rejection in kidney transplants","volume":"37","author":"Hoshinaga","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.08.003_bib8","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.transproceed.2006.06.026","article-title":"Effect of basiliximab on renal allograft rejection within 1 year after transplantation","volume":"38","author":"Lee","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.08.003_bib9","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.transproceed.2009.06.063","article-title":"Use of basiliximab induction in low\u2013immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression","volume":"41","author":"Gavela Martinez","year":"2009","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515007496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515007496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T06:55:18Z","timestamp":1537253718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134515007496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0041134515007496"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.08.003","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus, Mycophenolate Mofetil, and Low-Dose Steroids With or\u00a0Without Interleukin-2 Receptor Antibody Induction Therapy: A\u00a0Retrospective Cohort Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}